Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis
Key facts
- Who runs it
- Children's Hospital of Philadelphia
- Where
- Ann Arbor, Boston, Chicago, Cincinnati, Columbia, Columbus, Dallas, Davis, Denver, Emory, Houston, Los Angeles, Milwaukee, New York, Philadelphia, Pittsburgh, Providence, Richmond, Salt Lake City, San Francisco, Seattle, and St Louis, United StatesSee the 22 sites
- Trial code
- Status
- Completed
- Phase
- Phase 3
- People taking part
- 9,041 people enrolled
- Started
- 25 Aug 2020
- Ended
- 31 Jan 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Lactated Ringer
- Normal Saline
- Plasma-lyte
- Record updated
- 5 March 2026
Who can take part
- Age
- 2 months to 17 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Males or females age >2 months to <18 years
- Clinician concern for septic shock, operationalized as:; a "positive" ED sepsis alert confirmed by a physician OR; physician decision to treat for septic shock OR; a physician diagnosis of septic shock requiring parenteral antibiotics and fluid resuscitation
- Administration of at least one IV/Intraosseous (IO) fluid bolus for resuscitation and additional fluid deemed likely to be necessary to treat poor perfusion, or clinician judgment that >1 fluid bolus is highly likely to be required. Poor perfusion is defined as physician's judgement of hypotension or abnormal (either "flash" or "prolonged") capillary refill
- Receipt of ≤40 mL/kg IV/IO total crystalloid fluid prior to randomization
- Parental/guardian permission (informed consent) if time permits; otherwise, Exception from informed consent (EFIC) criteria met
Who cannot take part
- Indication of declined consent to participate based on presence of an opt-out bracelet with appropriate messaging embossed into the bracelet, the presence of the patient's name on an opt-out list that will be kept up-to-date and checked prior to randomization, or verbal "opt-out" prior to enrollment
- Known allergy to a crystalloid fluid
- Treating physician judges that patient's condition deems it unsafe to administer either NS or BF (since patients will be equally likely to receive NS or BF at time of study enrollment), including:; Clinical suspicion for impending brain herniation; Known hyperkalemia, defined as non-hemolyzed whole blood or plasma/serum potassium > 6 mEq/L, based on data available at or before patient meets criteria for study enrollment; Known hypercalcemia, defined as plasma/serum total calcium >12 mg/dL or whole blood ionized calcium >1.35 mmol/L, based on data available at or before patient meets criteria for study enrollment; Known acute fulminant hepatic failure, defined as plasma/serum alanine aminotransferase (ALT) >10,000 U/L or total bilirubin >12.0 mg/dL, based on data available at or before patient meets criteria for study enrollment; Known history of severe hepatic impairment, defined as cirrhosis, "liver failure", or awaiting transplant; Known history of severe renal impairment, defined as peritoneal dialysis or hemodialysis; Known metabolic/mitochondrial disorder, inborn error of metabolism, or primary mineralocorticoid deficiency as reported by participant, legally authorized representative (LAR) or accompanying caregiver, or as listed in the medical record; Other concern for which the treating clinician deems it unsafe to administer either NS or LR
- Known pregnancy determined by routine history disclosed by patient and/or accompanying acquaintance
- Known prisoner
Where in United States
- CS Mott Children's HospitalAnn Arbor, United States
- Boston Children's HospitalBoston, United States
- Lurie Children's: Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, United States
- Cincinnati Children's Hospital Medical CenterCincinnati, United States
- Children's National Medical CenterColumbia, United States
- Nationwide Children's HospitalColumbus, United States
- Dallas Children's: Children's Medical Center Dallas/UT southwesternDallas, United States
- UC Davis: University of California, DavisDavis, United States
- Children's Colorado: University of ColoradoDenver, United States
- Children's Hospital of AtlantaEmory, United States
- Texas Children's HospitalHouston, United States
- CHLA: Children's Hospital Los AngelesLos Angeles, United States
- Milwaukee (MCW): Medical College of WisconsinMilwaukee, United States
- Columbia: New York-Presbyterian HospitalNew York, United States
- The Children's Hospital Of PhiladelphiaPhiladelphia, United States
- Children's Hospital of PittsburghPittsburgh, United States
- Hasbro Children's HospitalProvidence, United States
- Children's Hospital of Richmond at VCURichmond, United States
- Primary Children's/University of UtahSalt Lake City, United States
- UCSF Benioff Children's HospitalSan Francisco, United States
- Seattle Children's HospitalSeattle, United States
- Washington UniversitySt Louis, United States
About the trial
What the trial wants to find out
The objectives of this multicenter pragmatic clinical trial are to compare the effectiveness and relative safety of balanced fluid resuscitation versus 0.9% "normal" saline in children with septic shock, including whether balanced fluid resuscitation can reduce progression of kidney injury.
The 2 groups in the trial
- Balanced fluids (BF)Treatment being tested
Balanced fluids (BF), including Lactated Ringer's and Plasma-Lyte (PL), will be administered to patients randomized to the experimental arm. BF will be used for all fluid boluses and maintenance fluids (supplemental electrolytes are allowed) from time immediately after randomization through 11:59 pm of the next calendar day. The determination of when to give fluid, how much fluid to give, how fast to give fluid, and what access to use to administer fluid will remain at the discretion of the treating team.
Treatment: Lactated Ringer and Plasma-lyte
- 0.9% "Normal" Saline Fluid (NS)Existing treatment, for comparison
0.9% "normal" saline (NS) fluid will be administered to patients randomized to the active comparator (control) arm. NS will be used for all fluid boluses and maintenance fluids (supplemental electrolytes are allowed) from time immediately after randomization through 11:59 pm of the next calendar day. The determination of when to give fluid, how much fluid to give, how fast to give fluid, and what access to use to administer fluid will remain at the discretion of the treating team.
Treatment: Normal Saline
Results explained
A paper that names this trial, explained in plain words.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Balanced Fluid or 0.9% Saline in Children Treated for Septic Shock.The New England journal of medicine, 2026
- PRagMatic Pediatric Trial of Balanced vs nOrmaL Saline FlUid in Sepsis: study protocol for the PRoMPT BOLUS randomized interventional trial.Trials, 2021
- Record updated
- 5 March 2026